Skip to main content
Log in

A steric approach for the design of antihistamines with low muscarinic receptor antagonism

  • 5. Histamine metabolism, receptors and antihistamines
  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Remy DC, Rittle KE, Hunt CA, Anderson PS, Engelhardt EL, Clineschmidt BV et al. (+)- and (−)-3-Methoxycyproheptadine: a comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine. J Med Chem 1977;20:1681–4.

    Google Scholar 

  2. Itoh Y, Kato H, Koshinaka E, Ogawa N, Nishino H, Sakaguchi J. Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same. Eur Patent No 0 399 414 A1 (1990).

  3. Zhang M-Q, Ter Laak AM, Timmerman H. Structure-activity relationships within a series of analogues of the histamine H1-antagonist terfenadine. Eur J Med Chem 1993;28:165–73.

    Google Scholar 

  4. Casy AF. Antihistamine drugs. In Handbook of Stereoisomers: Therapeutic Drugs. (Ed. Smith DF and Boca Raton FL) pp. 149–164, CRC Press, 1989.

  5. Eglen RM, Reddy H, Watson N, Challiss RAJ. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 1994;15:114–9.

    Google Scholar 

  6. Polymeropoulos EE, Kutscher B, Fleischhauer I. Computerassisted analysis of the possible binding sites of H1-antagonists. In QSAR: Rational Approaches to the Design of Bioactive Compounds. (Ed. Silipo C and Vittoria A) pp. 261–264, Elsevier Science Publishers B.V., Amsterdam 1991.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, M.Q., Walczynski, K. & Timmerman, H. A steric approach for the design of antihistamines with low muscarinic receptor antagonism. Inflamm Res 44 (Suppl 1), S90–S91 (1995). https://doi.org/10.1007/BF01674411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01674411

Keywords

Navigation